These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 27610455)
1. Sulfated Hyaluronan Alters the Interaction Profile of TIMP-3 with the Endocytic Receptor LRP-1 Clusters II and IV and Increases the Extracellular TIMP-3 Level of Human Bone Marrow Stromal Cells. Rother S; Samsonov SA; Hempel U; Vogel S; Moeller S; Blaszkiewicz J; Köhling S; Schnabelrauch M; Rademann J; Pisabarro MT; Hintze V; Scharnweber D Biomacromolecules; 2016 Oct; 17(10):3252-3261. PubMed ID: 27610455 [TBL] [Abstract][Full Text] [Related]
2. Structural and functional insights into the interaction of sulfated glycosaminoglycans with tissue inhibitor of metalloproteinase-3 - A possible regulatory role on extracellular matrix homeostasis. Rother S; Samsonov SA; Hofmann T; Blaszkiewicz J; Köhling S; Moeller S; Schnabelrauch M; Rademann J; Kalkhof S; von Bergen M; Pisabarro MT; Scharnweber D; Hintze V Acta Biomater; 2016 Nov; 45():143-154. PubMed ID: 27545813 [TBL] [Abstract][Full Text] [Related]
3. Sulfated Hyaluronan Alters Endothelial Cell Activation in Vitro by Controlling the Biological Activity of the Angiogenic Factors Vascular Endothelial Growth Factor-A and Tissue Inhibitor of Metalloproteinase-3. Rother S; Samsonov SA; Moeller S; Schnabelrauch M; Rademann J; Blaszkiewicz J; Köhling S; Waltenberger J; Pisabarro MT; Scharnweber D; Hintze V ACS Appl Mater Interfaces; 2017 Mar; 9(11):9539-9550. PubMed ID: 28248081 [TBL] [Abstract][Full Text] [Related]
4. Sulfated glycosaminoglycans control the extracellular trafficking and the activity of the metalloprotease inhibitor TIMP-3. Troeberg L; Lazenbatt C; Anower-E-Khuda MF; Freeman C; Federov O; Habuchi H; Habuchi O; Kimata K; Nagase H Chem Biol; 2014 Oct; 21(10):1300-1309. PubMed ID: 25176127 [TBL] [Abstract][Full Text] [Related]
6. Thermodynamic profiles of the interactions of suramin, chondroitin sulfate, and pentosan polysulfate with the inhibitory domain of TIMP-3. Logue T; Lizotte-Waniewski M; Brew K FEBS Lett; 2020 Jan; 594(1):94-103. PubMed ID: 31359422 [TBL] [Abstract][Full Text] [Related]
7. Dissecting the interaction between tissue inhibitor of metalloproteinases-3 (TIMP-3) and low density lipoprotein receptor-related protein-1 (LRP-1): Development of a "TRAP" to increase levels of TIMP-3 in the tissue. Scilabra SD; Yamamoto K; Pigoni M; Sakamoto K; Müller SA; Papadopoulou A; Lichtenthaler SF; Troeberg L; Nagase H; Kadomatsu K Matrix Biol; 2017 May; 59():69-79. PubMed ID: 27476612 [TBL] [Abstract][Full Text] [Related]
8. Sulfated glycosaminoglycans exploit the conformational plasticity of bone morphogenetic protein-2 (BMP-2) and alter the interaction profile with its receptor. Hintze V; Samsonov SA; Anselmi M; Moeller S; Becher J; Schnabelrauch M; Scharnweber D; Pisabarro MT Biomacromolecules; 2014 Aug; 15(8):3083-92. PubMed ID: 25029480 [TBL] [Abstract][Full Text] [Related]
9. TIMP-3 facilitates binding of target metalloproteinases to the endocytic receptor LRP-1 and promotes scavenging of MMP-1. Carreca AP; Pravatà VM; Markham M; Bonelli S; Murphy G; Nagase H; Troeberg L; Scilabra SD Sci Rep; 2020 Jul; 10(1):12067. PubMed ID: 32694578 [TBL] [Abstract][Full Text] [Related]
10. Structural and functional insights into sclerostin-glycosaminoglycan interactions in bone. Salbach-Hirsch J; Samsonov SA; Hintze V; Hofbauer C; Picke AK; Rauner M; Gehrcke JP; Moeller S; Schnabelrauch M; Scharnweber D; Pisabarro MT; Hofbauer LC Biomaterials; 2015 Oct; 67():335-45. PubMed ID: 26232882 [TBL] [Abstract][Full Text] [Related]
12. Sulfated hyaluronan alters fibronectin matrix assembly and promotes osteogenic differentiation of human bone marrow stromal cells. Vogel S; Arnoldini S; Möller S; Schnabelrauch M; Hempel U Sci Rep; 2016 Nov; 6():36418. PubMed ID: 27808176 [TBL] [Abstract][Full Text] [Related]
13. Sulfated hyaluronan containing collagen matrices enhance cell-matrix-interaction, endocytosis, and osteogenic differentiation of human mesenchymal stromal cells. Kliemt S; Lange C; Otto W; Hintze V; Möller S; von Bergen M; Hempel U; Kalkhof S J Proteome Res; 2013 Jan; 12(1):378-89. PubMed ID: 23170904 [TBL] [Abstract][Full Text] [Related]
14. Sulfated hyaluronan and chondroitin sulfate derivatives interact differently with human transforming growth factor-β1 (TGF-β1). Hintze V; Miron A; Moeller S; Schnabelrauch M; Wiesmann HP; Worch H; Scharnweber D Acta Biomater; 2012 Jul; 8(6):2144-52. PubMed ID: 22426137 [TBL] [Abstract][Full Text] [Related]
15. Osteoblast-released Matrix Vesicles, Regulation of Activity and Composition by Sulfated and Non-sulfated Glycosaminoglycans. Schmidt JR; Kliemt S; Preissler C; Moeller S; von Bergen M; Hempel U; Kalkhof S Mol Cell Proteomics; 2016 Feb; 15(2):558-72. PubMed ID: 26598647 [TBL] [Abstract][Full Text] [Related]
16. Sulfated hyaluronan/collagen I matrices enhance the osteogenic differentiation of human mesenchymal stromal cells in vitro even in the absence of dexamethasone. Hempel U; Möller S; Noack C; Hintze V; Scharnweber D; Schnabelrauch M; Dieter P Acta Biomater; 2012 Nov; 8(11):4064-72. PubMed ID: 22771456 [TBL] [Abstract][Full Text] [Related]